Close Menu

As sequencing becomes ever cheaper, genome profiling will move from being used in the clinic in cases of rare diseases to more everyday health issues, says Amy Dockser Marcus in The Wall Street Journal. "Whole-genome sequencing will not stay confined to extremely rare cases of obscure diseases," says Robert Green from Brigham and Women's Hospital and Harvard Medical School.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.